As AML1‐ETO and c‐KIT gene abnormalities are associated with poor outcome of patients with t(8;21) AML (Jiao et al, 2009; Qin et al, 2014), we examined the relationships among expression of THAP10, AML1‐ETO and c‐KIT in newly diagnosed t(8;21) AML patients (Appendix Table S5). This evidence concerns the gene THAP10 and acute myeloid leukemia.